{"id":4628,"date":"2022-09-09T08:44:53","date_gmt":"2022-09-09T08:44:53","guid":{"rendered":"https:\/\/synexagroup.com\/?page_id=4628"},"modified":"2022-09-09T09:03:20","modified_gmt":"2022-09-09T09:03:20","slug":"sitemap","status":"publish","type":"page","link":"https:\/\/synexagroup.com\/sitemap","title":{"rendered":"Sitemap"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"4628\" class=\"elementor elementor-4628\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bd6fc72 elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"bd6fc72\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3f57ef3\" data-id=\"3f57ef3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-5af7569 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5af7569\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-d65f7cc\" data-id=\"d65f7cc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-301a553 elementor-widget elementor-widget-heading\" data-id=\"301a553\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 18-04-2024 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h1 class=\"elementor-heading-title elementor-size-default\">Sitemap<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-99079dd sitemap elementor-widget elementor-widget-shortcode\" data-id=\"99079dd\" data-element_type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-shortcode\"><div class=\"aioseo-html-sitemap\"><style>.aioseo-html-sitemap.labels-hidden ul { margin: 0; }<\/style><div class=\"aioseo-html-page-sitemap\"><h4>Pages<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/leadership\" >Leadership (July 16, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/bioanalytical-science\" >Bioanalytical Science (July 17, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/about-synexa\" >About Synexa (July 21, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/biomarker-science\" >Biomarker Science (July 28, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/research-and-development\" >Research and Development (July 29, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/pharmacokinetics\" >Pharmacokinetics (August 4, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/new-header\" >New Header (September 23, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/quality-assurance\" >Operations (June 7, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/\" >Home (June 11, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/therapeutic-expertise\" >Therapeutic Expertise (June 14, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/careers\" >Careers (August 25, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news\" >News (November 2, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/pbmc-isolation\" >PBMC Isolation (November 11, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinars\" >Webinars (December 1, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/privacy\" >Privacy (February 11, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/cookie-policy\" >Cookie-policy (February 11, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/terms-of-use\" >Terms of use (February 11, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/executive-board\" >Executive Board (May 11, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/non-executive-team\" >Non-Executive Team (May 11, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/contact-sales\" >Contact Sales (May 27, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/submit-rfi-rfp\" >Submit RFI\/RFP (May 30, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/career-enquiries\" >Career Enquiries (May 30, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/general-enquiries\" >General Enquiries (June 6, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sitemap\" >Sitemap (September 9, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/events\" >Events (February 17, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/thank-you\" >Thank you (June 8, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/impressum\" >Impressum (June 9, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/about\" >About (October 19, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/clinically-relevant-solutions\" >Solutions for Clinical Research (October 20, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/prototrials\" >Prototrials (October 24, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/synexa-team\" >Synexa Team (October 25, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/biomarker-solutions-and-services\" >Biomarker- Solutions (October 25, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/bioanalysis\" >Bioanalysis (October 26, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/biomarker-consulting\" >Biomarker Consulting (October 26, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/tissue-imaging-cell-solutions\" >Tissue Imaging &#038; Cell Solutions (October 26, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/flow-cytometry-services\" >Flow Cytometry (October 26, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/why-synexa\" >Why Synexa (October 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/vaccines\" >Vaccines (October 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/autoimmune\" >Autoimmune (October 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/biosimilars\" >Biosimilars (October 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/immuno-oncology\" >Immuno Oncology (October 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/kimberg-internship\" >Kimberg Internship (November 1, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/opportunities\" >Opportunities (November 1, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/why-join-synexa\" >Why Join Synexa (November 6, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/contact\" >Contact (November 6, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/proteomics\" >Proteomics (February 2, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/genetics\" >Genetics (April 23, 2024)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-strong_foundations-sitemap\"><h4>Blog Articles<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/a-unifying-expression-signature-for-sle\" >A unifying  expression  signature for SLE (July 16, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/complement-c4-genes-and-sex-biased-disease-susceptibility\" >Complement C4 Genes and Sex-Biased Disease Susceptibility (July 16, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/potential-concussion-biomarkers-discovered-in-circulating-blood-after-brain-injury\" >Potential concussion biomarkers discovered in circulating blood after brain injury (July 16, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/immune-checkpoint-inhibitors-and-mdscs\" >Immune checkpoint inhibitors and MDSCs (July 16, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/faecal-calprotectin-as-a-biomarker-in-crohns-disease\" >Faecal Calprotectin as a biomarker in Crohn\u2019s disease (July 24, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/immune-biomarkers-in-depression\" >Immune biomarkers in depression (July 24, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/rapid-expansion-of-treg-cells-protects-from-collateral-colitis-following-a-viral-trigger\" >Rapid expansion of Treg cells protects from collateral colitis following a viral trigger (September 18, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/the-prospect-of-immunotherapy-for-combating-alzheimers-disease\" >The prospect of immunotherapy for combating Alzheimer\u2019s disease (September 18, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/macrophages-transfer-mitochondria-to-sensory-neurons-to-resolve-inflammatory-pain\" >Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain (September 18, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/spot-on-use-of-dried-blood-spots-dbs-for-serological-immunoassays\" >Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays (September 18, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/th17-cells-and-il-17-a-possible-link-between-inflammation-and-neuronal-decline-in-multiple-sclerosis\" >Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis (September 18, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/infertility-and-the-importance-of-the-endometrial-immune-balance\" >Infertility and the importance of the endometrial immune balance (February 15, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/the-biomarker-association-between-depression-and-vascular-disease\" >The Biomarker Association between Depression and Vascular Disease (February 15, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/rare-diseases-day\" >Synexa raises awareness for Rare Diseases Day (February 28, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/lipids-as-biomarkers-of-brain-disorders\" >Lipids as Biomarkers of Brain Disorders (March 24, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/fibrosis-and-smad-signalling\" >Fibrosis and SMAD signalling (April 22, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/guide-biomarker-solutions\" >A Quick Guide to Biomarker Solutions (August 3, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/where-does-bioanalysis-fit-into-drug-discovery-pipelines\" >Where Does Bioanalysis Fit into Drug Discovery Pipelines? (August 19, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/what-immune-checkpoint-inhibitors\" >What are Immune Checkpoint Inhibitors? (August 26, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/how-accelerate-pre-clinical-trials-with-flow-cytometry\" >How to Accelerate Pre-Clinical Trials with Flow Cytometry (September 21, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/how-to-measure-bacteriophages-in-clinical-studies-for-antimicrobial-agents\" >How to Measure Bacteriophages in Clinical Studies for Antimicrobial Agents (September 30, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/enhancing-pcr-molecular-diagnostics-using-immunoassays\" >Enhancing PCR Molecular Diagnostics Using Immunoassays (October 7, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/a-brief-introduction-to-novel-modalities\" >A Brief Introduction To Novel Modalities (November 2, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/using-exosomes-as-clinical-biomarkers\" >Using Exosomes As Clinical Biomarkers (November 18, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/how-immunogenomics-factors-into-cell-and-gene-studies\" >How Immunogenomics Factors into Cell and Gene Studies (November 29, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/what-biomarkers-are-used-for-cns-drug-development\" >What Biomarkers Are Used For CNS Drug Development? (February 9, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/understanding-the-role-of-phenotypic-assays-in-drug-research\" >Understanding the Role of Phenotypic Assays in Drug Research (February 24, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/how-cytokine-release-assays-work-in-predictive-immunotoxicology\" >How Cytokine Release Assays Work in Predictive Immunotoxicology (March 10, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/world-tuberculosis-day\" >The Current State of Tuberculosis Research | World TB Day (March 24, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/parkinsons-disease-biomarker-assessment-new-approaches-and-directions\" >Parkinson\u2019s Disease Biomarker Assessment: New Approaches and Directions (April 11, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/improving-the-worlds-first-malaria-vaccine\" >Improving the World&#8217;s First Malaria Vaccine (April 26, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/monitoring-immune-response-in-pediatric-vaccine-recipients\" >Monitoring Immune Response in Pediatric Vaccine Recipients (April 27, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/asthma-care-for-all\" >Asthma Care for All (May 2, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/biomarkers-for-dementia\" >Biomarkers for Dementia (May 17, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/challenges-and-opportunities-development-of-the-hiv-vaccine\" >Challenges and Opportunities: Development of the HIV vaccine (May 18, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/liquid-biopsies-a-non-invasive-picture-of-cancer-physiology\" >Liquid biopsies: a non-invasive picture of cancer physiology (July 12, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/advances-in-autoimmune-hepatitis-biomarkers-improving-diagnosis-and-treatment-outcomes\" >Advances in Autoimmune Hepatitis Biomarkers: Improving Diagnosis and Treatment Outcomes (July 28, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/revolutionizing-lung-cancer-treatment-with-car-t-cell-therapy\" >Revolutionizing Lung Cancer Treatment with CAR-T Cell Therapy (August 1, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/biomarkers-in-saliva-a-novel-approach-to-endometriosis\" >Biomarkers in saliva: A novel approach to endometriosis (August 17, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/the-standardization-of-synuclein-seed-amplification-assays\" >The standardization of synuclein seed amplification assays (August 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/uncovering-tissue-complexity-through-spatial-biology\" >Uncovering tissue complexity through spatial biology (September 15, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/ai-assisted-pathology-for-precision-medicine-are-we-there-yet\" >AI-assisted pathology for precision medicine: Are we there yet? (October 5, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-bioanalytical-strategies-for-cell-therapies\" >Bioanalytical Strategies for Cell Therapy Clinical Trials (December 6, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-top-3-biotech-trends-in-2024-dr-nicholas-woudberg\" >Top 3 Biotech Trends in 2024 | Dr. Nicholas Woudberg (January 8, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-top-3-biotech-trends-in-2024-dr-caroline-beltran\" >Top 3 Biotech Trends in 2024 | Dr. Caroline Beltran\u00a0 (January 9, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-the-criticality-of-early-detection-of-pre-eclampsia-new-biomarkers\" >The criticality of early detection of pre-eclampsia: New biomarkers (January 24, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-mycobacterium-leprae-the-lazy-cousin-to-tuberculosis\" >Mycobacterium leprae: The lazy cousin to Tuberculosis\u00a0 (January 29, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/https-synexagroup-com-blog-articles-world-cancer-day-2024-closing-the-gap\" >World Cancer Day 2024: Closing the gap (February 5, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/modelling-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp-a-rare-autoimmune-disease\" >Modelling Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A rare autoimmune disease (February 29, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/cardiovascular-complications-in-chronic-kidney-disease-new-biomarkers-and-treatment\" >Cardiovascular complications in chronic kidney disease: New biomarkers and treatment (March 13, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/bridging-the-gap-translating-animal-model-findings-to-clinical-oncology-breakthroughs\" >Bridging the Gap: Translating Animal Model Findings to Clinical Oncology Breakthroughs (March 20, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/from-pottiphar-to-potts-skeletal-tb-from-ancient-egypt-to-the-present-day\" >From Pottiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day (April 5, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/primary-immunodeficiency-week-a-complex-landscape-of-genetic-disorders-and-the-promise-of-gene-therapy\" >Primary Immunodeficiency Week: A complex landscape of genetic disorders (April 23, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/blog-articles\/primary-immunodeficiency-week-the-promise-of-gene-therapy\" >Primary Immunodeficiency Week: The promise of gene therapy (April 25, 2024)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-deep_insight-sitemap\"><h4>Feature Articles<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/feature-articles\/lack-of-implantation-of-an-embryo-when-the-numbers-count\" >Lack of implantation of an embryo: when the numbers count (July 23, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/feature-articles\/sars-cov-2-when-does-the-calm-become-the-perfect-storm\" >SARS CoV-2: when does the calm become the perfect storm? (July 24, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/feature-articles\/nanostring-ncounter-technology-covid-19-immunological-and-inflammatory-response\" >NanoString nCounter Technology \u2013 COVID-19 Immunological and Inflammatory Response (October 2, 2020)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/feature-articles\/immunogenicity-101-antidrug-antibodies-neutralizing-antibodies-and-everything-in-between\" >Immunogenicity 101: Antidrug Antibodies, Neutralizing Antibodies, and everything in between (January 20, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/feature-articles\/behind-the-wave\" >Behind the wave (May 20, 2021)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-brochures-sitemap\"><h4>Brochures<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/Brochures\/covid-19-biomarker-analysis\" >COVID-19: Biomarker Analysis (March 23, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/measurement-of-phosphorylated-smad-2-3\" >Measurement of phosphorylated SMAD-2\/3 (March 23, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/bioanalytical-solutions-for-immuno-oncology-therapeutics\" >Bioanalytical Solutions for Immuno-oncology Therapeutics (August 10, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/prototrials\" >ProtoTrials\u00ae (August 10, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/global-leader-in-biomarker-bioanalysis\" >Synexa Biomarker and Bioanalytical Solutions (August 10, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/laboratory-solutions-for-vaccine-clinical-trials\" >Laboratory Solutions for Vaccine Clinical Trials (August 24, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/bioanalytical-solutions-for-car-t-and-nk-cell-therapies\" >Bioanalytical Solutions for CAR-T and NK Cell Therapies (August 24, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/complete-laboratory-solution-for-vaccine-studies\" >Complete Laboratory Solution for Vaccine Studies (November 9, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/translational-services-for-gastroenterology-research\" >Translational Services for Gastroenterology Research (January 19, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/lupus-biomarker-discovery\" >Lupus Biomarker Discovery (January 26, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/allogeneic-cell-therapy-services\" >Allogeneic Cell Therapy Services (January 26, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/Brochures\/biomarker-and-bioanalysis-solution-for-pulmonary-disease\" >Biomarker and Bioanalysis Solution for Pulmonary Disease (April 23, 2024)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-webinar-sitemap\"><h4>webinars<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/webinar\/accelerating-tb-vaccine-development-insights-from-microsampling-biomarkers-and-data-analysis\" >Accelerating TB Vaccine Development: Insights from Microsampling, Biomarkers and Data Analysis (May 18, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/enhancing-flow-cytometry-precision-and-accuracy-in-immuno-oncology-studies-investigating-immune-cell-phenotypes-functions-and-target-interactions\" >Enhancing Flow Cytometry Precision and Accuracy in Immuno-Oncology Studies (August 28, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/neutralizing-antibody-assays-approach-to-design-and-analysis\" >Neutralising antibody assays: approach to design and analysis (February 28, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/from-potiphar-to-potts-skeletal-tb-from-ancient-egypt-to-the-present-day\" >From Potiphar to Potts: Skeletal TB from Ancient Egypt to the Present Day (March 28, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/persistence-is-key-bioanalytical-strategies-for-cell-therapy-clinical-trials-2\" >Persistence is key: Bioanalytical Strategies for Cell Therapy Clinical Trials (April 9, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/the-human-touch-patient-derived-data-from-synexa-prototrials\" >The Human Touch; patient-derived data from Synexa Prototrials\u00ae (April 11, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/webinar\/searching-for-immunological-beauty\" >Searching for Immunological Beauty (April 18, 2024)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-datasheet-sitemap\"><h4>Datasheets<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/datasheet\/covid-19-serology-testing\" >COVID-19 Serology Testing (March 23, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/datasheet\/biosimilar-research-and-development-expertise\" >Biosimilar Research and Development Expertise (March 23, 2021)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-news-articles-sitemap\"><h4>News<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-announces-tripartite-collaboration\" >Synexa Announces Tripartite Collaboration (March 23, 2021)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-co-founder-and-ceo-to-become-companys-chairman\" >Synexa Life Sciences Co-founder and CEO to become company\u2019s Chairman (May 13, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-announces-strategic-growth-plans-and-strengthening-of-its-executive-team\" >Synexa Life Sciences announces strategic growth plans and strengthening of its executive team (May 18, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-acquires-finnish-cro-syrinx-bioanalytics-to-expand-bioanalysis-capabilities\" >Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities (May 19, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-expands-operations-in-north-america-with-new-rockville-laboratory-site\" >Synexa Life Sciences expands operations in North America with new Rockville laboratory site (June 13, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-to-appoint-chief-commercial-officer-to-support-company-growth-ambitions\" >Synexa Life Sciences to appoint Chief Commercial Officer to support company growth ambitions (August 19, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-celebrates-its-20th-anniversary\" >Synexa Life Sciences celebrates its 20th anniversary (March 3, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-joins-cepi-in-advancing-global-epidemic-preparedness-and-response\" >Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response (May 30, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-hosts-german-parliamentary-sub-committee-on-global-health-at-cape-town-laboratories\" >Synexa Life Sciences hosts German Parliamentary Sub-Committee on Global Health at Cape Town laboratories (February 9, 2024)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/news-articles\/synexa-life-sciences-expands-biomarker-discovery-capabilities-with-the-addition-of-olink-target-platform\" >Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink\u00ae Target Platform (March 4, 2024)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-job_vacancies-sitemap\"><h4>Job Vacancies<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/infrastructure-officer\" >Infrastructure Officer (September 8, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/laboratory-technician\" >Laboratory Technician (October 28, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/laboratory-technician-sa\" >Laboratory Technician (October 31, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/medical-biomedical-laboratory-technician\" >Medical\/Biomedical laboratory technician (October 31, 2022)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/research-associate\" >Research Associate (January 12, 2023)<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_vacancies\/procurement-logistics-officer\" >Procurement &#038; Logistics Officer (January 20, 2023)<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-di_tags-sitemap\"><h4>Tags<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/di_tags\/covid-19\" >COVID-19<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/cytokines\" >cytokines<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/immune-response\" >immune response<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/ace2\" >ACE2<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/drug-target\" >drug target<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/embryology\" >Embryology<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/ivf\" >IVF<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/fertility\" >fertility<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/microbiome\" >microbiome<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/nanostring\" >NanoString<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/immunogenomics\" >Immunogenomics<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/therapeutics\" >therapeutics<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/vaccines\" >vaccines<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/surveillance\" >surveillance<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/efficacy\" >efficacy<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/safety\" >safety<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/clinical-trials\" >clinical trials<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/clinical-research\" >clinical research<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_tags\/sars-cov-2\" >SARS-CoV-2<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-di_categories-sitemap\"><h4>Categories<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/di_categories\/research\" >Research<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/di_categories\/biomarkers\" >Biomarkers<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-sf_tags-sitemap\"><h4>Tags<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/crohns-disease\" >Crohn\u2019s disease<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/immune-checkpoints\" >Immune checkpoints<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/ici\" >ICI<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/immunotherapy\" >immunotherapy<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/mdsc\" >MDSC<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/oncology\" >oncology<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/depression\" >Depression<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/psychiatry\" >psychiatry<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/crp\" >CRP<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/il6\" >IL6<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/ibd\" >IBD<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/calprotectin\" >calprotectin<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/git\" >GIT<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/concussion\" >Concussion<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/brain-injury\" >brain injury<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/gfap\" >GFAP<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/nf-l1\" >NF-L1<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/uch-l1\" >UCH-L1<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/lupus\" >Lupus<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/sle\" >SLE<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/autoimmune\" >autoimmune<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/transcriptome\" >transcriptome<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/neuroscience\" >Neuroscience<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/treg\" >Treg<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/ulcerative-colitis\" >ulcerative colitis<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/neurodegeneration\" >neurodegeneration<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/cytokines\" >cytokines<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/parkinsons-disease\" >Parkinson\u2019s disease<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/interleukins\" >Interleukins<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/il-17\" >IL-17<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/t-helper-cells\" >T helper cells<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/cns\" >CNS<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/hdl\" >HDL<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/cholesterol\" >cholesterol<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/alzheimers-disease\" >Alzheimer&#039;s Disease<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/inflammation\" >inflammation<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/diagnostics\" >Diagnostics<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/dry-blood-spots\" >Dry blood spots<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/method-development\" >method development<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/lipids\" >lipids<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/ldl\" >LDL<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/serology\" >serology<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/infertility\" >Infertility<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/endometrial-immune-profiling\" >endometrial immune profiling<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/nk-cells\" >NK cells<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/mdd\" >MDD<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/cvd\" >CVD<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/complement\" >complement<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/fibrosis\" >Fibrosis<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/t-cells\" >T-cells<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/transforming-growth-factor-beta\" >Transforming growth factor beta<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/tgf-%ce%b2\" >TGF-\u03b2<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/smad\" >SMAD<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/wound-healing\" >Wound healing<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/integrins\" >Integrins<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/macrophages\" >Macrophages<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/monoclonal-antibodies\" >Monoclonal antibodies<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/kinase-inhibitors\" >Kinase inhibitors<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/pain\" >pain<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/bacteriophages\" >Bacteriophages<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/antimicrobial-agents\" >Antimicrobial agents<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/sf_tags\/multiple-sclerosis\" >Multiple Sclerosis<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-ds_category-sitemap\"><h4>Categories<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/ds_category\/news\" >News<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/ds_category\/partnership\" >Partnership<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/ds_category\/organisational-news\" >Organisational News<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-job_category-sitemap\"><h4>Job Categories<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/job_category\/science\" >Science<\/a><\/li><li><a href=\"https:\/\/synexagroup.com\/job_category\/procurement\" >Procurement<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-job_type-sitemap\"><h4>Job Types<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/job_type\/full-time\" >Full Time<\/a><\/li><\/ul><\/div><br \/><div class=\"aioseo-html-location-sitemap\"><h4>Locations<\/h4><ul><li><a href=\"https:\/\/synexagroup.com\/location\/south-africa\" >South Africa<\/a><ul><li><a href=\"https:\/\/synexagroup.com\/location\/cape-town\" >Cape Town<\/a><\/li><\/ul><\/li><li><a href=\"https:\/\/synexagroup.com\/location\/uk\" >UK<\/a><ul><li><a href=\"https:\/\/synexagroup.com\/location\/london\" >London<\/a><\/li><\/ul><\/li><li><a href=\"https:\/\/synexagroup.com\/location\/germany\" >Germany<\/a><ul><li><a href=\"https:\/\/synexagroup.com\/location\/berlin\" >Berlin<\/a><\/li><\/ul><\/li><\/ul><\/div><br \/><\/div><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Sitemap<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/pages\/4628"}],"collection":[{"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/comments?post=4628"}],"version-history":[{"count":0,"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/pages\/4628\/revisions"}],"wp:attachment":[{"href":"https:\/\/synexagroup.com\/wp-json\/wp\/v2\/media?parent=4628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}